ICP
NVRO

Interchange Capital Partners’s NEVRO CORP. NVRO Stock Holding History

Interchange Capital Partners’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9
Closed -$1K – 1149
2020
Q4 		$1K Buy
+9
New +$1.46K ﹤0.01% 1179

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Interchange Capital Partners's NVRO Position: Q1 2021 in Review

Interchange Capital Partners sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 9 shares — an estimated $1K sold.

Interchange Capital Partners first reported a position in NVRO in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

  • Interchange Capital Partners reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 9 NEVRO CORP. shares in Q1 2021, an estimated $1K.
  • Interchange Capital Partners first reported a position in NEVRO CORP. in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's NEVRO CORP. position peaked at $1K in Q4 2020.
  • 204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.